Scientists discover how TB 'develops invincibility' against only available treatment

March 13, 2008

Scientists at the University of Leicester have uncovered a dramatic new twist in the battle against TB. They have identified how the killer bacterium makes itself immune to a key component of the only effective treatment against the disease.

Earlier this month, a separate team of TB researchers at Leicester announced a new advance in their fight against the resurgence of TB in Britain. They isolated the molecular ‘weapons’ of the bacterium and are assessing ways to make the bacterium impotent.

Now, in new research published in the Journal of Biological Chemistry, another team from the Departments of Biochemistry and Chemistry at the University has shown how the TB bacteria becomes resistant to one of the only available treatments for the killer disease.

Dr Peter Moody of the Biochemistry Department said: “Isoniazid is a pro-drug that an enzyme in the deadly bacteria itself makes active.

“Using the technique of protein crystallography and the incredibly bright X-ray source of the European Synchrotron at Grenoble, my team and that of Professor Emma Raven of the Chemistry Department at Leicester along with Dr Katherine Brown of Imperial College have shown how the pro-drug binds to two very similar enzymes - and from this we can see how mutations in the bacterial enzyme protect it from the treatment.”

This is the first time anyone has seen the way the pro-drug binds to activating enzymes.

Dr Moody said: "Drug-resistant forms of TB are approaching 10% of the 8000 cases a year in the UK, so understanding how this works is very important."

The researchers hope that this new understanding will help drug companies devise treatments for the resistant strains.

Dr Moody added: “Unfortunately, development of the UK synchrotron source (Diamond) is under threat because of the shortfall in funding, which could limit our ability to do this sort of fundamental medical research in the future”.

Citation: The Tuberculosis Prodrug Isoniazid Bound to Activating Peroxidases. Clive Metcalfe, Isabel K. Macdonald, Emma J. Murphy, Katherine A. Brown, Emma Lloyd Raven, and Peter C. E. Moody J. Biol. Chem., Vol. 283, Issue 10, 6193-6200, March, 2008

Source: University of Leicester

Related Stories

Recommended for you

Atlas of the RNA universe takes shape

December 7, 2016

As the floor plan of the living world, DNA guides the composition of animals ranging from unicellular organisms to humans. DNA not only helps shepherd every organism from birth through death, it also plays an essential role ...

Giant radio flare of Cygnus X-3 detected by astronomers

December 7, 2016

(Phys.org)—Russian astronomers have recently observed a giant radio flare from a strong X-ray binary source known as Cygnus X-3 (Cyg X-3 for short). The flare occurred after more than five years of quiescence of this source. ...

Dark matter may be smoother than expected

December 7, 2016

Analysis of a giant new galaxy survey, made with ESO's VLT Survey Telescope in Chile, suggests that dark matter may be less dense and more smoothly distributed throughout space than previously thought. An international team ...

Uncovering the secrets of water and ice as materials

December 7, 2016

Water is vital to life on Earth and its importance simply can't be overstated—it's also deeply rooted within our conscience that there's something extremely special about it. Yet, from a scientific point of view, much remains ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.